| Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism C Monteiro, L Miarka, M Perea-García, N Priego, P Garcia-Gomez, ... Nature medicine 28 (4), 752-765, 2022 | 58 | 2022 |
| Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells H Knaack, L Lenk, LM Philipp, L Miarka, S Rahn, F Viol, C Hauser, ... Oncotarget 9 (60), 31771, 2018 | 33 | 2018 |
| Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal … A Fabian, S Stegner, L Miarka, J Zimmermann, L Lenk, S Rahn, J Buttlar, ... Cancer letters 453, 95-106, 2019 | 32 | 2019 |
| Animal models of brain metastasis L Miarka, M Valiente Neuro-Oncology Advances 3 (Supplement_5), v144-v156, 2021 | 27 | 2021 |
| A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis L Zhu, D Retana, P García‐Gómez, L Álvaro‐Espinosa, N Priego, ... EMBO molecular medicine 14 (3), e14552, 2022 | 18 | 2022 |
| The hepatic microenvironment and TRAIL-R2 impact outgrowth of liver metastases in pancreatic cancer after surgical resection L Miarka, C Hauser, O Helm, D Holdhof, S Beckinger, JH Egberts, ... Cancers 11 (6), 745, 2019 | 16 | 2019 |
| A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis L Zhu, N Yebra, D Retana, L Miarka, E Hernández-Encinas, ... Biorxiv, 2020.10. 16.329243, 2020 | 4 | 2020 |
| Protocol to generate murine organotypic brain cultures for drug screening and evaluation of anti-metastatic efficacy L Zhu, L Miarka, P Baena, M Perea-García, M Valiente STAR protocols 4 (2), 102194, 2023 | 3 | 2023 |
| P02. 01 A strategy to personalize the use of radiation in patients with brain metastasis based on S100A9-mediated resistance L Miarka, C Monteiro, C Dalmasso, N Yebra, C Fustero-Torre, A Hegarty, ... Neuro-Oncology 23 (Supplement_2), ii17-ii17, 2021 | | 2021 |
| RADI-03. A strategy to personalize the use of radiation in patients with brain metastasis based on S100A9-mediated resistance L Miarka, C Moteiro, C Dalmasso, C Fustero-Torre, N Yebra, A Hegarty, ... Neuro-Oncology Advances 3 (Supplement_3), iii18-iii18, 2021 | | 2021 |
| Abstract PO-068: S100A9 mediates radiation resistance of brain metastasis L Miarka, C Monteiro, C Dalmasso, N Yebra, C Fustero-Torre, A Hegarty, ... Clinical Cancer Research 27 (8_Supplement), PO-068-PO-068, 2021 | | 2021 |
| Metastasierung des duktalen Pankreasadenokarzinoms: Wechselwirkung der hepatischen Mikroumgebung und TRAIL-Rezeptoren sowie ihr Einfluss auf malignitäts-assoziierte Prozesse … L Miarka | | 2020 |
| Supplementary Materials: The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection L Miarka, C Hauser, O Helm, D Holdhof, S Beckinger, JH Egberts, ... | | |
Lennart LenkPrincipal Investigator, UKSH Campus Kiel在 uksh.de 的电子邮件经过验证
